Table 2: Montelukast 10 mg: Baseline evaluation versus 12 weeks of treatment.

Finding Baseline Evaluation
(n = 104)
Evaluation 12 Weeks
(n = 104)
p
n % n %
Last month treatment schedule includes corticosteroids 68 65.4 54 51.9 0.048
Use of rescue inhaled B2 last month 68 65.4 51 49.0 0.017
Attended the emergency room in the last month for asthma 14 13.5 9 8.7 0.13
Wheezing in the consultation 51 49.0 30 28.9 0.002
p50 IQR p50 IQR p
Attacks in the past month 2 1 0 0 0.00
Symptom-free days in the last month 15 6.5 24.5 1.0 0.00

p50: 50th percentile; IQR: Interquartile range (p75-p25); p: p value.